Weekly vs Twice-Weekly Testosterone
With long-acting esters (cypionate or enanthate), weekly and twice-weekly cadence are both clinically valid. Twice-weekly is the modern default for most candidates because it produces a more stable trough, smoother estradiol behavior, and steadier subjective signal.
Weekly cadence is appropriate when injection burden is the priority and biomarker stability is acceptable.
Explore pathwayTwice-weekly cadence is the modern default for most candidates due to steadier trough and smoother estradiol behavior.
Explore pathwayEducational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Does twice-weekly require more total testosterone?
No — total weekly dose is unchanged; it is split across two injections.
When is once-weekly preferred?
When candidate preference for fewer injections outweighs the marginal benefit of steadier trough.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment